Probiotics in the management of children with allergy and other disorders of intestinal inflammation

Beneficial Microbes

Volumn 1, Issue 4, 2010, Pages 351-356

  Vanderhoof, J A ^a   Mitmesser, S H ^a  

^a Mead Johnson Nutritionals   (United States)

Author keywords

Allergy; Diarrhoea; Infants; LGG; Probiotics

Indexed keywords

PROBIOTIC AGENT;

CHILD; GASTROINTESTINAL DISEASE; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; LACTOBACILLUS; MICROBIOLOGY; PHYSIOLOGY; REVIEW;

CHILD; GASTROINTESTINAL DISEASES; HUMANS; HYPERSENSITIVITY; LACTOBACILLUS; PROBIOTICS;

EID: 84856372959     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2010.0034     Document Type: Article

References (53)

1. Alfaleh, K. and Bassler, D., 2008. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database of Systematic Reviews 2008 (1): CD005496.
2. Baldassarre, M., Laforgia, N., Fanelli, M., Laneve, A., Grosso, R. and Lifschitz, C., 2010. Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone. Journal of Pediatrics 156: 397-401.
3. Bin-Nun, A., Bromiker, R., Wilschanski, M., Kaplan, M., Rudensky, B., Caplan, M. and Hammerman, C., 2005. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. Journal of Pediatrics 147: 192-196.
4. Boirivant, M. and Strober, W. 2007. The mechanism of action of probiotics. Current Opinion in Gastroenterology 23: 679-692.
5. Bousvaros, A., Guandalini, S., Baldassano, R., Botelho, C., Evans, J., Ferry, G., Goldin, B., Hartigan, L., Kugathasan, S., Levy, J., Murray, K., Oliva-Hemker, M., Rosh, J., Tolia, V., Zholudev, A., Vanderhoof, J. and Hibberd, P., 2005. A randomized, doubleblind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflammatory Bowel Diseases 11: 833-839.
6. Cary, V.A. and Boullata, J., 2010. What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease? Journal of Clinical Nursing 19: 904-916.
7. Costa-Ribeiro, H., Ribeiro, T., Mattos, A., Valois, S., Neri, D., Almeida, P., Cerqueira, C., Ramos, E., Young, R. and Vanderhoof, J., 2003. Limitations of probiotic therapy in acute, severe dehydrating diarrhea. Journal of Pediatric Gastroenterology and Nutrition 36: 112-115.
8. Cox, M.J., Huang, Y.J., Fujimura, K.E., Liu, J.E., McKean, M., Boushey, H.A., Segal, M.R., Brodie, E.L., Cabana, M.D. and Lynch, S.V., 2010. Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome. PloS ONE 5: e8745.
9. Dobrogosz, W.J., Peacock, T.J. and Hassan, H.M., 2010. Evolution of the probiotic concept from conception to validation and acceptance in medical science. Advances in Applied Microbiology 72: 1-41.
10. Fuller, R., 1991. Probiotics in human medicine. Gut 32: 439-442.
11. Grüber, C., Wendt, M., Sulser, C., Lau, S., Kulig, M., Wahn, U., Werfel, T. and Niggemann, B., 2007. Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy 62: 1270-1276.
12. Hatakka, K., Savilahti, E., Pönkä, A., Meurman, J.H., Poussa, T., Näse, L., Saxelin, M. and Korpela, R., 2001. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322: 1327-1331.
13. Helin, T., Haahtela, S. and Haahtela, T., 2002. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATTCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 57: 243-246.
14. Hilton, E., Kolakowski, P., Singer, C. and Smith, M., 1997. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. Journal of Travel Medicine 4: 41-43.
15. Hojsak, I., Abdovic, S., Szajewska, H., Milošecic, M., Krznaric, Ž. and Kolacek, S., 2010a. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 125: e1171-e1177.
16. Hojsak, I., Snovak, N., Abdovic, S., Szajewska, H., Mišak, Z. and Kolacek, S., 2010b. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebocontrolled trial. Clinical Nutrition 29: 312-316
17. Horii, K., Simon, S., Liu, D. and Sharma, V., 2007. Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns. Pediatrics 120: e527-e534.
18. Hörmannsperger, G. and Haller, D., 2010. Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease. International Journal of Medical Microbiology 300: 63-73.
19. International Study of Asthma and Allergies in Childhood Steering Committee (ISAAC), 1998. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczems: ISAAC. The Lancet 351: 1225-1232.
20. Isolauri, E., Juntunen, M., Rautanen, T., Sillanaukee, P. and Koivula, T., 1991. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88: 90-97.
21. Isolauri, E., Arvola, T., Sütas, Y., Moilanen, E. and Salminen, S., 2000. Probiotics in the management of atopic eczema. Clinical and Experimental Allergy 30: 1604-1610.
22. Jung, L., 1999. Lactobacillus GG augments the immune response to typhoid vaccination: a double-blind, placebo-controlled study. FASEB Journal 13: A872.
23. Kaila, M., Isolauri, E., Soppi, E, Virtanen, E., Laine, S. and Arvilommi, H., 1992. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatric Research 32: 141-144.
24. Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P. and Isolauri, E., 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. The Lancet 357: 1076-1079.
25. Krämer, U., Heinrich, J., Wjst, M. and Wichmann, H., 1999. Age of entry to day nursery and allergy in later childhood. The Lancet 353: 450-454.
26. Kukkonen, K., Savilahti, E., Haahtela, T., Juntunen-Backman, K., Korpela, R., Poussa, T., Tuure, T. and Kuitunen, M., 2007. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. Journal of Allergy and Clinical Immunology 119: 192-198.
27. Lee, J., Seto, D. and Bielory, L., 2008. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. Journal of Allergy and Clinical Immunology 121: 116-121.
28. Lin, H., Hsu, C.-H., Chen, H.-L., Chung, M.-Y., Hsu, J.-F., Lien, R.-I., Tsao, L.-Y., Chen, C.-H. and Su, B.-H., 2008. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 122: 693-700.
29. Loftus, E.V., 2004. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517.
30. Mack, D., Michail, S., Wei, S., McDougall, L. and Hollingsworth, M., 1999. Probiotics inhibit enteropathogenic E. coli adherance in vitro by inducing intestinal mucin gene expression. American Journal of Physiology - Gastrointestinal and Liver Physiology 276: 941-950.
31. Mack, D., Ahrne, S., Hyde, L., Wei, S. and Hollingsworth, M., 2003. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52: 827-833.
32. Majamaa, H. and Isolauri, E., 1997. Probiotics: a novel approach in the management of food allergy. Journal of Allergy and Clinical Immunology 99: 179-185.
33. Mannino, D., Homa, D., Akinbami, L., Moorman, J., Gwynn, C. and Redd, S., 2002. Surveillance for asthma - United States, 1980-1999. MMWR Surveillance Summaries 51: 1-13.
34. Mattar, A., Teitelbaum, D., Drongowski, R., Yongyi, F., Harmon, C. and Coran, A., 2002. Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatric Surgery International 18: 586-590.
35. Montgomery, S., Wakefield, A., Morris, D., Pounder, R. and Murch, S., 2000. The initial care of newborn infants and subsequent hay fever. Allergy 55: 916-922.
36. Ohland, C.L. and MacNaughton, W.K., 2010. Probiotic bacteria and intestinal epithelial barrier function. American Journal of Physiology - Gastrointestinal and Liver Physiology 298: G807-G819.
37. Pagnini, C., Saeed, R., Bamias, G., Arseneau, K.O., Pizarro, T.T. and Cominelli, F. 2010. Probiotics promote gut health through stimulation of epithelial innate immunity. Proceedings of the National Academy of Sciences of the USA 107: 454-459.
38. Pohjavuori, E., Viljanen, M., Korpela, R., Kuitunen, M., Tiittanen, M., Vaarala, O. and Savilahti, E., 2004. Lactobacillus GG effect in increasing IFN-γ production in infants with cow's milk allergy. Journal of Allergy and Clinical Immunology 114: 131-136.
39. Polz, M. and Jablonski, L., 1986. Nosocomial infection in children's hospital: a retrospective study. Journal of Hygiene, Epidemiology, Microbiology and Immunology 30: 149-153.
40. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. and Medzhitov, R., 2004. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
41. Rautava, S., Kalliomäki, M. and Isolauri, E., 2002. Probiotics during pregnancy and breastfeeding might confer immunomodulatory protection against atopic disease in the infant. Journal of Allergy and Clinical Immunology 109: 119-121.
42. Rautava, S., Ruuskanen, O., Ouwehand, A., Salminen, S. and Isolauri, E., 2004. The hygiene hypothesis of atopic disease: an extended version. Journal of Pediatric Gastroenterology and Nutrition 38: 378-388.
43. Romagnani, S., 1994. Regulation of the development of type 2 T-helper cells in allergy. Current Opinion in Immunology 6: 838-846.
44. Rosenfeldt, V., Benfeldt, E., Valerius, N., Paerregaard, A. and Michaelsen, K., 2004. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. Journal of Pediatrics 145: 612-616.
45. Saavedra, J., Bauman, N., Oung, I., Perman, J. and Yolken, R., 1994. Feeding Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. The Lancet 344: 1046-1049.
46. Schultz, M., Göttl, C., Young, R., Iwen, P. and Vanderhoof, J., 2004. Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization. Journal of Pediatric Gastroenterology and Nutrition 38: 293-297.
47. Sly, R., 1999. Changing prevalence of allergic rhinitis and asthma. Annals of Allergy, Asthma and Immunology 82: 233-248; quiz 248-252.
48. Vanderhoof, J., Whitney, D., Antonson, D., Hanner, T., Lupo, J. and Young, R., 1999. Lactobacillus GG in the prevention of antibioticassociated diarrhea in children. Journal of Pediatrics 135: 564-568.
49. Walker-Smith, J. and Murch, S. (eds.), 1999. Diseases of the small intestine in childhood. Isis Medical Media, Oxford, UK.
50. Welliver, R. and McLaughin, S., 1984. Unique epidemiology of nosocomial infection in children's hospital. American Journal of Diseases of Children 138: 131-135.
51. Weston, S., Halbert, A., Richmond, P. and Prescott, S., 2005. Effects of probiotics on atopic dermatitis: a randomized controlled trial. Archives of Disease in Childhood 90: 892-897.
52. Wold, A., 1998. The hygiene hypothesis revised: is the rising frequency of allergy due to changes in the intestinal flora? Allergy 53: S20-S25.
53. Wolvers, D., Antoine, J.-M., Myllyluoma, E., Schrezenmeir, J., Szajewska, H. and Rijkers, G.T., 2010. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. Journal of Nutrition 140: 698S-712S.